HIGHLIGHTS
- who: Kathleen J. Till from the DepartmentUniversity of have published the article: Roles of PI3Ku03b3 and PI3Ku03b4 in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Ku03b3/u03b4 inhibitor duvelisib, in the Journal: Scientific Reports Scientific Reports
- what: The authors show that PI3Ku03b3 is expressed by MCL cells and impacts multiple points of the disease process that are important for disease progression (Fig 5).
- how: The data is in line with the fact that inhibition of mTOR and AKT downstream targets of PI3K have been shown to result in decreased . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.